2021 Hepatitis B SIG: Expanding HBV Treatment Criteria, New Biomarkers and Cure Updates
Recorded On: 11/11/2021
Already registered?
Sign in now.
Available, safe, and effective oral antiviral therapies help manage complications in patients with HBV, who are at increased risk for infection reactivation as they age due to increased exposure to biologics for various comorbidities. Experts will share advances in novel diagnostic and prognostic biomarkers, when hepatologists should consider prophylactic antiviral therapy, and research advances toward an HBV cure.
Complete
Next
Failed
Available
Locked